Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder

Stem Cell Res. 2016 Nov;17(3):514-516. doi: 10.1016/j.scr.2016.09.035. Epub 2016 Oct 3.

Abstract

Peripheral blood was collected from a 39-year-old unaffected female carrier of an X-linked recessive mutation of Iduronate 2-sulfatase gene (NM_000202.7(IDS):c.85C>T) causing MPS II (OMIM 309900). Peripheral blood mononuclear cells (PBMCs) were reprogrammed by lentiviral delivery of a self-silencing hOKSM polycistronic vector. The pluripotency of iPSC line was confirmed by the expression of pluripotency-associated markers and in vitro spontaneous differentiation towards the 3 germ layers. The iPSC showed normal karyotype. The line offers a good platform to study MPS II pathophysiology, for drug testing, early biomarker discovery and gene therapy studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Base Sequence
  • Cell Differentiation
  • Cell Line
  • Cellular Reprogramming
  • Embryoid Bodies / cytology
  • Embryoid Bodies / metabolism
  • Female
  • Genetic Vectors / genetics
  • Genetic Vectors / metabolism
  • Glycoproteins / genetics*
  • Humans
  • Induced Pluripotent Stem Cells / cytology*
  • Induced Pluripotent Stem Cells / metabolism
  • Karyotype
  • Lentivirus / genetics
  • Leukocytes, Mononuclear / cytology
  • Microscopy, Fluorescence
  • Mucopolysaccharidosis II / genetics
  • Mucopolysaccharidosis II / pathology*
  • Polymorphism, Single Nucleotide
  • Sequence Analysis, DNA
  • Transcription Factors / genetics
  • Transcription Factors / metabolism

Substances

  • Glycoproteins
  • IDS protein, human
  • Transcription Factors